Romanelli Robert J, Shenoy Rivfka, Martinez Meghan C, Mudiganti Satish, Mariano Louis T, Zanocco Kyle A, Wagner Zachary, Kirkegaard Allison, Watkins Katherine E
RAND Europe, Cambridge, England.
University of California, Los Angeles, CA, USA.
Arch Public Health. 2023 May 6;81(1):83. doi: 10.1186/s13690-023-01095-2.
To examine racial and ethnic disparities in postoperative opioid prescribing.
Electronic health records (EHR) data across 24 hospitals from a healthcare delivery system in Northern California from January 1, 2015 to February 2, 2020 (study period).
Cross-sectional, secondary data analyses were conducted to examine differences by race and ethnicity in opioid prescribing, measured as morphine milligram equivalents (MME), among patients who underwent select, but commonly performed, surgical procedures. Linear regression models included adjustment for factors that would likely influence prescribing decisions and race and ethnicity-specific propensity weights. Opioid prescribing, overall and by race and ethnicity, was also compared to postoperative opioid guidelines.
Data were extracted from the EHR on adult patients undergoing a procedure during the study period, discharged to home with an opioid prescription.
Among 61,564 patients, on adjusted regression analysis, non-Hispanic Black (NHB) patients received prescriptions with higher mean MME than non-Hispanic white (NHW) patients (+ 6.4% [95% confidence interval: 4.4%, 8.3%]), whereas Hispanic and non-Hispanic Asian patients received lower mean MME (-4.2% [-5.1%, -3.2%] and - 3.6% [-4.8%, -2.3%], respectively). Nevertheless, 72.8% of all patients received prescriptions above guidelines, ranging from 71.0 to 80.3% by race and ethnicity. Disparities in prescribing were eliminated among Hispanic and NHB patients versus NHW patients when prescriptions were written within guideline recommendations.
Racial and ethnic disparities in opioid prescribing exist in the postoperative setting, yet all groups received prescriptions above guideline recommendations. Policies encouraging guideline-based prescribing may reduce disparities and overall excess prescribing.
研究术后阿片类药物处方中的种族和民族差异。
来自北加利福尼亚州一个医疗保健系统中24家医院的电子健康记录(EHR)数据,时间跨度为2015年1月1日至2020年2月2日(研究期)。
进行横断面的二次数据分析,以研究接受特定但常见外科手术的患者中,按种族和民族划分的阿片类药物处方差异,以吗啡毫克当量(MME)衡量。线性回归模型对可能影响处方决策的因素以及种族和民族特异性倾向权重进行了调整。还将总体以及按种族和民族划分的阿片类药物处方与术后阿片类药物指南进行了比较。
从EHR中提取研究期间接受手术且出院时开具阿片类药物处方的成年患者的数据。
在61564名患者中,经调整回归分析,非西班牙裔黑人(NHB)患者收到的处方平均MME高于非西班牙裔白人(NHW)患者(+6.4%[95%置信区间:4.4%,8.3%]),而西班牙裔和非西班牙裔亚洲患者收到的平均MME较低(分别为-4.2%[-5.1%,-3.2%]和-3.6%[-4.8%,-2.3%])。然而,所有患者中有72.8%收到的处方超过了指南规定,按种族和民族划分,这一比例在71.0%至80.3%之间。当处方按照指南建议开具时,西班牙裔和NHB患者与NHW患者之间的处方差异消除。
术后阿片类药物处方中存在种族和民族差异,但所有群体收到的处方均高于指南建议。鼓励基于指南开具处方的政策可能会减少差异和总体过度处方情况。